What's the value in leveraging prospective data vs. retrospective data in PMC/PMR studies?

There are many factors to consider when deciding between retrospective data and prospective data use in postmarketing commitments and postmarketing requirements. In this video, Flatiron's Vice President of Research Oncology shares criteria for sponsors to weigh, when making a decision. 

Other videos from this series:

• What role does technology play in PMC/PMR studies, supported by Flatiron?

• What role do services play in PMC/PMR studies, supported by Flatiron?

• How do technology and operational services complement each other in PMC/PMR studies, supported by Flatiron?

• How are PMC/PMR studies different for sites, compared to traditional studies?

• How do sites support PMC/PMR studies today and how might that look differently, working with Flatiron?

• What are the challenges sponsors face today when pursuing a PMR/PMR study?

• Why is patient enrollment challenging for PMC/PMR studies?

• What does a pragmatic approach to PMR/PMRs, look like for sponsors?

• What's the consequence of failure in PMC/PMR studies?

• How does Flatiron reduce the burden of PMC/PMR studies for sponsors, sites, and patients?

• How does Flatiron help sponsors make decisions on what data to use in a PMC/PMR study?